Diagnosis: Primary cutaneous diffuse large B-cell lymphoma, leg type
An 82-year-old woman presents with a solitary red-violet tumor on her lower leg that has been increasing in size over the past three months. Examination reveals a firm, non-tender lesion with irregular borders, prompting further investigation into a potential cutaneous malignancy.
An 82-year-old woman presents with a solitary red-violet tumor on her lower leg, which has been gradually increasing in size over the past three months. The lesion is asymptomatic, with no associated pruritus or pain on examination.Lesion Characteristics: Firm, non-tender, red-violet tumor measuring approximately 3 cm in diameter.Border Irregularity: The lesion has irregular borders, with a slightly raised surface.Surrounding Skin: No significant erythema or ulceration of the surrounding skin.Lymphadenopathy: No palpable regional lymphadenopathy noted on examination.Systemic Symptoms: Patient denies fever, weight loss, or night sweats.
The lesion first appeared approximately three months ago, beginning as a small bump that gradually enlarged. The patient reports no known triggers for the lesion and has not sought treatment prior to this visit. Her past medical history includes hypertension and hyperlipidemia, managed with medication. There is no significant family history of skin cancers or lymphomas. Social history is notable for a history of sun exposure during outdoor activities.Onset: Lesion onset approximately three months ago.Prior Treatments: No previous treatments attempted for the lesion.Past Medical History: Hypertension and hyperlipidemia.Family History: No significant family history of malignancies.Social History: History of significant sun exposure.
Acute / First-Line ManagementExcision: Complete surgical excision of the lesion is the first-line treatment for solitary cutaneous lymphomas, aiming for clear margins.Radiation Therapy: Considered for patients not eligible for surgery or with residual disease; typically involves low-energy X-rays.Workup and Diagnostic ConfirmationBiopsy: Excisional biopsy of the lesion should be performed to obtain histopathological confirmation.Immunohistochemistry: Essential for determining the B-cell lineage and subtype, often showing CD19, CD20, and CD79a positivity.Staging: PET-CT may be utilized to assess for systemic involvement, especially in cases with larger lesions or concerning features.Long-Term ManagementFollow-Up: Regular follow-up is necessary to monitor for recurrence and manage any late effects of treatment.Systemic Therapy: In cases of advanced or refractory disease, consider rituximab or chemotherapy regimens such as CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone).Supportive Care: Address any psychosocial needs and provide education about skin cancer surveillance.
Kaposi Sarcoma: Typically presents with multiple lesions, associated with HIV or immunosuppression; often purplish and may be seen on mucosal surfaces.Cutaneous Metastasis: Consider especially in patients with known malignancies; lesions often have a history of rapid growth.Dermatofibroma: Generally firm, brownish nodules; can be mistaken for malignancies but typically show characteristic histology.Granuloma Annulare: Presents as annular plaques, often self-limiting; usually asymptomatic and lacks the aggressive features of lymphoma.Basal Cell Carcinoma: Common skin malignancy with pearly borders; typically arises in sun-exposed areas but can have varied appearances.Squamous Cell Carcinoma: Presents as a keratotic or ulcerative lesion; history of sun exposure or actinic keratosis may be present.Mycosis Fungoides: A form of cutaneous T-cell lymphoma that typically presents with patches and plaques rather than solitary tumors.Primary Cutaneous Lymphoma (Other Types): Other subtypes may present with different clinical features; histopathology is crucial for differentiation.
High-Yield PearlsSolitary Lesion: A solitary red-violet tumor in an older individual warrants consideration of primary cutaneous lymphomas.Histological Confirmation: Accurate diagnosis requires histopathological examination and immunohistochemical staining.Excision vs. Non-Surgical Options: Surgical excision is the primary treatment; radiation may be utilized for non-surgical candidates.Follow-Up Importance: Regular follow-up is essential due to the risk of recurrence or secondary malignancies.Systemic Options: Advanced disease may require systemic therapies, including monoclonal antibodies like rituximab.A solitary red-violet tumor in an older adult is a potential indicator of cutaneous malignancy, necessitating thorough evaluation.
Tags: B-cell lymphoma cutis, PCBCL